Our dedicated team of seasoned healthcare investors provides strategic capital tailored to healthcare and pharma business timelines, whether to develop or launch new medicines, make asset acquisitions, or provide growth capital to finance strategic initiatives.
We are passionate about forming long-term partnerships with companies creating new technologies to address our most pressing healthcare challenges and improve patient care. Our experienced life sciences and technology teams focus on collaborating to develop AI and software-related themes within the healthcare space.
We invest across the sector and have partnered with companies in drug development and marketing, devices and diagnostics, generics, pharma and healthcare business services, and contract research, development and manufacturing.
We provide flexible and custom solutions and typically make investments in the form of non-dilutive financing or growth capital. We can help fund launches, capital projects, R&D, product acquisitions, business carveouts and other strategic initiatives. Our partnerships usually include the following types, although these elements are often combined or take the form of novel structures.
Working with both private and public companies, we can offer custom financings which sit between common equity and secured debt. Our solutions often include convertible preferred equity, redeemable preferred equity or convertible debt with the ability to combine these with a secured financing.
2018 Case study: Caris Life Sciences
Our team can work with companies on either passive royalty financings (company receives a passive third-party royalty) or synthetic royalty financings (company creates royalty on its own product). Royalty financings can include traditional royalty sales, structured royalty purchases (including annual or cumulative caps) or royalty-backed debt.Case study: Immunogen
We can work directly with companies to help bring new products or therapies to the market. Our structures can help companies achieve their financial, accounting and strategic aims all while retaining control of the development of their assets.
We have worked directly with healthcare funds to help fund the exit of assets at the end of fund life, acquire earnouts, or help fund incremental investments post LP commitment period. We can transact at the fund or asset level.
Irvine, California | www.alliancemedical.com
Alliance HealthCare Services is a leading national provider of outsourced medical services including radiology, oncology and interventional.
San Francisco, CA | www.datavant.com/
Datavant’s mission is to connect the world’s health data to improve patient outcomes.
ROCKVILLE, MD, USA | https://drfirst.com/
DrFirst provides healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes.
Richardson, Texas | www.medeanalytics.com
MedeAnalytics is a healthcare analytics innovator enabling healthcare providers and payers across the U.S. and U.K. to make smarter decisions in today’s new healthcare economy.
Carlsbad, California | www.medsphere.com
Medsphere Systems Corporation is an organization of committed clinical and technology professionals working to positively impact patient care by delivering award-winning healthcare IT solutions for providers of every size and budget.
San Francisco, California | www.nektar.com
Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients, including treatments of cancer, autoimmune disease and chronic pain.